Inflammatory processes in the brain and spinal cord feature prominently in conditions like multiple sclerosis, Alzheimer’s, Parkinson’s, Parkinsonian plus, and similar disorders. Affecting millions of patients worldwide, these diseases and their neuroinflammatory components have long been the focus of CNS researchers who seek to develop effective treatments. Explore this topic at our one-day symposium, where notable neuroscientists from academia, biotech and pharma will share their knowledge of neuroinflammation, its impact on widely studied diseases, and the current state of research. Our symposium will conclude with a reception.